CancerConnect recently partnered with Dana-Farber Cancer Institute’s Susan F. Smith Center for Women’s Cancers to provide you with the opportunity to engage with breast cancer experts Harold J. Burstein, MD, PhD, and Erica L. Mayer, MD, MPH, who answered questions and relayed important information about chemotherapy, hormonal therapy and targeted therapy for breast cancer.

On October 24-25, 2013, Dr. Burstein and Dr. Mayer were guest moderators on CancerConnect, a leading social media website for cancer patients and caregivers seeking information and support. Their Q&A session can be accessed in the breast cancer community here.

Image placeholder title

Dr. Burstein is a medical oncologist and clinical investigator in the Breast Oncology Center at Dana-Farber’s Susan F. Smith Center for Women’s Cancers. Dr. Burstein serves on the National Comprehensive Cancer Network Breast Cancer Panel, the CALGB Breast Committee and several working groups in the American Society of Clinical Oncology focusing on breast cancer. Click here for Dr. Burstein’s bio.

Recommended Articles

Image placeholder title

Ask the Experts About Circulating Tumor DNA in the Management of Cancer

Ask the Experts About Circulating Tumor DNA (ctDNA) in the Management of Cancer

Image placeholder title

Tisotumab Vedotin – Promising in Advanced Cervical Cancer

Novel precision cancer medicine promising for treatment of advanced ovarian cancer.

Image placeholder title

Checkpoint Inhibitor Immunotherapy for Treatment of Advanced Cervical Cancer

Checkpoint inhibitor immunotherapy prolongs survival and delays recurrence in advanced cervical cancer.

Image placeholder title

Dr. Mayer is a medical oncologist and clinical investigator in the Breast Oncology Center at Dana-Farber’s Susan F. Smith Center for Women’s Cancers. Her research focuses on novel therapies in the treatment of breast cancer. Click here for Dr. Mayer’s bio.

The breast cancer Q&A with Dr. Burstein and Dr. Mayer includes the following:

The Ask The Expert Series is made possible by support fromThe Personalized Medicine Foundation, Incyte Oncology, Abbvie, and CancerConnect. The "Ask The Expert" series is not medical advice nor is it a substitute for your doctor. It should serve as a guide to facilitate access to additional information and enhancement of a shared decision making process with your treating physician.